The quantity of oxygen consumed per 100 g of brain tissue is the cerebral metabolic rate of oxygen (CMRO₂). The brain makes up about 2% of body weight but uses roughly 20% of the body's resting oxygen, almost entirely to produce ATP for maintaining ion gradients and transmitting nerve signals. It has practically no oxygen reserves, so consciousness is lost within seconds when supply stops. CMRO₂ was first measured in humans with the Kety–Schmidt nitrous oxide method, which also gave the classic value of cerebral blood flow of about 50 mL/100 g/min. In this application the value is linked to redox processes, lipid peroxidation and thyroid regulation.
CMRO₂ = cerebral blood flow × (arterial O₂ content − jugular venous O₂ content)
The reference methods are invasive or use special imaging: blood sampling from the jugular bulb together with cerebral blood flow measurement, and positron emission tomography (PET) with labelled oxygen. In intensive care, jugular venous saturation and brain tissue oxygen probes are used to judge whether oxygen supply matches demand.
Anaesthesia and sedation (used therapeutically to protect the brain), hypothermia, coma, after cardiac arrest, advanced dementia, hypothyroidism, severe hypoglycaemia.
Seizures, fever, intense mental activity, agitation and delirium, stimulants, hyperthyroidism. Raised demand combined with reduced flow increases the risk of ischaemic injury.
for sudden confusion, loss of consciousness, seizures, or sudden weakness, numbness or speech difficulty.
This article is for general information and does not replace a consultation with a doctor. Measurements must be interpreted by a physician together with symptoms and other tests.
Published on 5 May 2024